biotech
biotech Articles
Dynavax Technologies Corp. (NASDAQ: DVAX) shares crumbled Monday morning after the company said that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA)....
Published:
Last Updated:
Motif Bio has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
PTC Therapeutics shares skyrocketed early on Friday after the company received positive news from the European Medicines Agency.
Published:
Last Updated:
Gilead Sciences has announced that the FDA has approved its once-a-day treatment for adults with chronic hepatitis B virus infection.
Published:
Last Updated:
Globally focused biopharmaceutical company BeiGene has filed with the U.S. Securities and Exchange Commission for a secondary offering.
Published:
Last Updated:
Now that the U.S. presidential election is over and Hillary Clinton is out of the picture, major biotech companies can breathe a little easier knowing that the pressure is off, if for just now at...
Published:
Last Updated:
Mylan N.V. (NASDAQ: MYL) released third-quarter earnings after markets closed on Wednesday. The company posted $1.38 in earnings per share (EPS) and $3.23 billion in revenue. The consensus estimates...
Published:
Last Updated:
Novavax, Inc. (NASDAQ: NVAX) reported third-quarter financial results after markets closed on Wednesday. The company said that it had a net loss of $0.24 per share and $3.2 million in revenue, versus...
Published:
Last Updated:
EpiPen maker Mylan is scheduled to report its third-quarter financial results after the markets close on Wednesday.
Published:
Last Updated:
Visterra has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
24/7 Wall St. has identified several immediate winners from a Donald Trump presidency. These are all surging higher.
Published:
Last Updated:
Novavax is scheduled to report its third-quarter financial results before the markets open on Wednesday.
Published:
Last Updated:
Concordia International announced its third-quarter financial results before the markets opened on Monday, as well as a key change in leadership.
Published:
Last Updated:
Shares of Ionis Pharmaceuticals and Biogen were on the move Monday morning after the companies announced positive interim results from a late-stage trial.
Published:
Last Updated:
If you just looked at formal Buy and Sell ratings from Wall Street analysts, you might assume that everything is still fine and hopeful for Gilead Sciences.
Published:
Last Updated: